Metformin vs Rituximab
Metformin vs Rituximab: Overview
This comparison examines the pharmacological differences between Metformin and Rituximab.
Mechanism of Action
Metformin: Activates AMP-activated protein kinase, decreasing hepatic glucose production.
Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.
Pharmacokinetics
Half-life: Metformin — 4-9 hours; Rituximab — 22 days.
Chemical Properties
Molecular Formula: Metformin — C4H11N5.
Molecular Weight: Metformin — 129.1640 g/mol.
Type: Metformin — Small molecule; Rituximab — Antibody.